Standout Papers

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b... 1998 2026 2007 2016 670
  1. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells (2007)
    Farbod Shojaei, Xiumin Wu et al. Nature Biotechnology
  2. Rho-mediated Contractility Exposes a Cryptic Site in Fibronectin and Induces Fibronectin Matrix Assembly (1998)
    Cuiling Zhong, Magdalena Chrzanowska‐Wodnicka et al. The Journal of Cell Biology
  3. Bv8 regulates myeloid-cell-dependent tumour angiogenesis (2007)
    Farbod Shojaei, Xiumin Wu et al. Nature

Immediate Impact

10 by Nobel laureates 26 from Science/Nature 181 standout
Sub-graph 1 of 14

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
87 intermediate papers

Works of Cuiling Zhong being referenced

Evidence for Pro-angiogenic Functions of VEGF-Ax
2016
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
2007 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Cuiling Zhong 1437 410 750 1007 829 18 2.7k
Joni D. Mott 1250 283 805 951 297 25 2.7k
Rubén A. Bartolomé 1124 391 483 998 640 47 2.2k
Dawn A. Kirschmann 2539 366 999 1160 405 39 3.4k
Alexander Stoeck 2457 461 1066 698 465 24 3.4k
Dian Feng 1518 420 451 634 311 27 2.7k
Rizwan Naeem 1711 190 918 1974 768 10 3.4k
Carolyn J. Sympson 1381 648 923 1135 307 14 2.7k
Saadia A. Karim 1777 216 717 1572 361 34 3.2k
Marcin Iwanicki 1630 561 532 1073 254 33 2.8k
Chris D. Madsen 1065 225 652 994 374 33 2.5k

All Works

Loading papers...

Rankless by CCL
2026